PróLab Biotecnologia is a well-established company founded in 1988 and operating in the biotechnology industry. The company operates in three distinct areas, with PróLab Biotecnologia serving over 1.6 million active clients and conducting an average of 3.8 thousand analyses per month. It is ranked as one of the leading laboratories in Microbiological and Physicochemical Quality Control in Brazil. The PróLab Analises Clínicas division offers a wide range of clinical tests, catering to private and insurance clients. Additionally, the company specializes in conducting additional entrance and exit exams, serving a large number of companies. In the field of genetics, the company operates as Geneticenter - Centro de Genética, conducting research and developing genetic diagnostics such as Paternity Tests and Hereditary Diseases. As the company's funding details and investor information are not provided, further insights into its financial backing and strategic partnerships would be beneficial for potential investors to better understand the company's growth prospects.
There is no investment information
No recent news or press coverage available for PróLab Biotecnologia.
We care about your data, and we'd love to use cookies make your experience better.
